Enzo Life Sciences

Enzo Life Sciences is a well-established, privately-held provider of essential research tools and contract services for the life sciences industry. Its core business revolves around enabling scientific discovery and biopharma development through a diversified portfolio spanning genomic analysis, protein detection, cellular imaging, and tissue-based applications, notably its AMPIVIEW® RNA probes and CELLESTIAL® dyes. The company operates on a hybrid business model, combining product sales with high-margin custom services and GMP manufacturing, catering to a global customer base from basic research through therapeutic development. With a strong intellectual property foundation and certifications for quality, Enzo is positioned as a key enabler in growing fields like spatial biology, cell therapy, and multiomics.

Integrated suite for genomic, protein, cellular, and tissue analysis centered on labeling, detection, and visualization technologies, including AMPIVIEW® RNA probes, ELISA, CELLESTIAL® dyes, and GMP services.

Operates in a crowded, competitive market dominated by global giants like Thermo Fisher Scientific, Abcam, and Bio-Techne. Enzo differentiates through its specialized detection chemistries, broad antibody portfolio, integrated multi-platform approach, and niche GMP manufacturing services for the biopharma sector.